文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

血浆蛋白质组与代谢组孟德尔随机化识别脓毒症治疗靶点

PLASMA PROTEOME, METABOLOME MENDELIAN RANDOMIZATION IDENTIFIES SEPSIS THERAPEUTIC TARGETS.
PubMed 文献 · Shock · 2024-08-28
一句话结论孟德尔随机化提示ICAM5与1,2,3-苯三酚硫酸盐(2)与脓毒症风险存在因果关联,ICAM5介导后者11.9%的总效应。

研究利用公共全基因组关联分析数据,以两样本孟德尔随机化探讨血浆蛋白质组、代谢组与脓毒症(含不同亚组)的因果关系,并行多变量与迭代孟德尔随机化及敏感性分析。结果识别25种增加脓毒症风险的血浆蛋白和34种保护性蛋白;P值校正(0.05/1306)后ICAM5与脓毒症易感性正相关(P=2.14E-05,OR=1.10,95%CI 1.05-1.15),并在三个脓毒症亚组中保持显著。识别29种风险代谢物和15种保护代谢物;校正(0.05/997)后1,2,3-苯三酚硫酸盐(2)升高与脓毒症风险增加相关(P=3.37E-05,OR=1.18,95%CI 1.09-1.28)。该代谢物增加ICAM5蛋白丰度(P=3.52E-04,OR=1.11,95%CI 1.04-1.17),未检测到异质性、多效性或反向因果;中介分析显示ICAM5介导其总效应的11.9%。

要点

  • P值校正(0.05/1306)后,ICAM5与脓毒症易感性正相关(P=2.14E-05,OR=1.10,95%CI 1.05-1.15),三个脓毒症亚组均显著。
  • P值校正(0.05/997)后,1,2,3-苯三酚硫酸盐(2)升高与脓毒症风险增加相关(P=3.37E-05,OR=1.18,95%CI 1.09-1.28)。
  • 1,2,3-苯三酚硫酸盐(2)增加ICAM5蛋白丰度(P=3.52E-04,OR=1.11,95%CI 1.04-1.17),未检测到异质性、多效性或反向因果。
  • 中介孟德尔随机化显示ICAM5介导1,2,3-苯三酚硫酸盐(2)对脓毒症进展总效应的11.9%。
  • 共识别25种增加风险、34种保护性血浆蛋白,以及29种风险、15种保护性血浆代谢物。

适用人群与场景

  • 利用公共全基因组关联分析数据探索血浆蛋白质组、代谢组与脓毒症(含不同脓毒症亚组)的关系。

研究设计与关键结果

  • 研究类型为孟德尔随机化研究,使用公共全基因组关联分析数据,行两样本、多变量与迭代孟德尔随机化及敏感性分析。
  • 识别25种增加脓毒症风险的血浆蛋白和34种保护性蛋白;P值校正(0.05/1306)后ICAM5与脓毒症易感性正相关(P=2.14E-05,OR=1.10,95%CI 1.05-1.15),三个脓毒症亚组均保持显著。
  • 识别29种脓毒症风险代谢物和15种保护性代谢物;P值校正(0.05/997)后1,2,3-苯三酚硫酸盐(2)升高与脓毒症风险增加相关(P=3.37E-05,OR=1.18,95%CI 1.09-1.28)。
  • 1,2,3-苯三酚硫酸盐(2)增加ICAM5蛋白丰度(P=3.52E-04,OR=1.11,95%CI 1.04-1.17),未检测到异质性、多效性或反向因果。
  • 中介孟德尔随机化显示ICAM5介导1,2,3-苯三酚硫酸盐(2)对脓毒症进展总效应的11.9%。

证据类型、等级与局限

  • 证据类型:孟德尔随机化研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background : The interrelation between the plasma proteome and plasma metabolome with sepsis presents a multifaceted dynamic that necessitates further research to elucidate the underlying causal mechanisms. Methods : Our investigation used public genome-wide association study data to explore the relationships among the plasma proteome, metabolome, and sepsis, considering different sepsis subgroup. Initially, two-sample Mendelian randomization established causal connections between the plasma proteome and metabolome with sepsis. Subsequently, multivariate and iterative Mendelian randomization analyses were performed to understand the complex interactions in plasma during sepsis. The validity of these findings was supported by thorough sensitivity analyses. Result : The study identified 25 plasma proteins that enhance risk and 34 that act as protective agents in sepsis. After P value adjustment (0.05/1306), ICAM5 emerged with a positive correlation to sepsis susceptibility ( P value = 2.14E-05, OR = 1.10, 95% CI = 1.05-1.15), with this significance preserved across three sepsis subgroup examined. Additionally, 29 plasma metabolites were recognized as risk factors, and 15 as protective factors for sepsis outcomes. After P value adjustment (0.05/997), elevated levels of 1,2,3-benzenetriol sulfate (2) was significantly associated with increased sepsis risk ( P value = 3.37E-05, OR = 1.18, 95% CI = 1.09-1.28). Further scrutiny revealed that this plasma metabolite notably augments the abundance of ICAM5 protein ( P value = 3.52E-04, OR = 1.11, 95% CI = 1.04-1.17), devoid of any detected heterogeneity, pleiotropy, or reverse causality. Mediated Mendelian randomization revealed ICAM5 mediated 11.9% of 1,2,3-benzenetriol sulfate (2)'s total effect on sepsis progression. Conclusion : This study details the causal link between the plasma proteome and metabolome with sepsis, highlighting the roles of ICAM5 and 1,2,3-benzenetriol sulfate (2) in sepsis progression, both independently and through crosstalk.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Deng R, Huang G, Zhou J, et al. PLASMA PROTEOME, METABOLOME MENDELIAN RANDOMIZATION IDENTIFIES SEPSIS THERAPEUTIC TARGETS. Shock. 2024. PMID: 39194222. doi:10.1097/SHK.0000000000002465

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。